Andrés Morales Corado is a board-certified medical geneticist and metabolic disease specialist. He earned his medical degree at the Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala, completed pediatric residency at Lincoln Medical Center/Weill Cornell Medical College, and trained in Clinical Genetics and Genomics and Medical Biochemical Genetics in the Division of Medical Genetics at Stanford University. He is triple board-certified in Pediatrics, Clinical Genetics and Genomics, and Medical Biochemical Genetics, and a Fellow of the American College of Medical Genetics and Genomics (FACMG). Prior to UCLA, he served as Assistant Professor of Pediatrics at Columbia University and Associate Program Director of its Medical Genetics and Genomics residency.

His clinical and research work centers on the diagnosis and treatment of inborn errors of metabolism and rare diseases, spanning lysosomal storage disorders and the mucopolysaccharidoses, mitochondrial disease, neurometabolic and white-matter disorders including metabolic leukodystrophies, urea cycle and other small-molecule disorders, with particular emphasis on emerging therapeutics and gene therapy, newborn screening, and the natural history of ultra-rare conditions. He is Principal Investigator of an NIH-funded natural history study of Sanfilippo syndrome type D (MPS IIID), and he is increasingly engaged in the applications of artificial intelligence and large language models to rare disease diagnosis, care, and therapeutics.

Dr. Morales Corado is an active voice in national rare-disease policy: within the American College of Medical Genetics and Genomics he serves on the Therapeutics and Program Committees, where he has organized and moderated sessions on gene therapy, off-label use of therapeutics, and the clinical challenges of an emerging therapeutic era; and within the National Organization for Rare Disorders he co-chairs the Newborn Screening Workgroup and contributes to its Clinical Applications Workgroup. He is also a committed educator and advocate beyond the United States, lecturing regularly at Guatemala's national pediatrics meetings, residency programs and raising public awareness of rare disease through Guatemalan media, while also contributing to international genetics training, including the Indonesian Society of Genetic Counselors.